Kazuaki Takahashi

6PUBLICATIONS
125CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersObstetrics and gynaecologyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 24, 2026
Impact of platinum-free interval on the efficacy of lenvatinib plus pembrolizumab in advanced or recurrent endometrial cancer.

|Jul 25, 2026
Outcome of advanced ovarian cancer patients who do not undergo cytoreductive surgery in the era of PARP inhibitors maintenance therapy: a propensity score-based analysis.

|Jun 05, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.

Flurina A M Saner, Kazuaki Takahashi, Timothy Budden

|Apr 05, 2024
A retrospective study of dose-dense paclitaxel and carboplatin plus bevacizumab as first-line treatment of advanced epithelial ovarian cancer.

Hiromi Komazaki, Kazuaki Takahashi, Hiroshi Tanabe

|Sep 23, 2022
Outcomes of Pregnancies and Deliveries of Patients Who Underwent Fertility-Preserving Surgery for Early-Stage Epithelial Ovarian Cancer.

Shin Nishio, Takayo Takeno, Takeshi Fukuda

|Jan 29, 2020
Rethinking of treatment strategies and clinical management in ovarian clear cell carcinoma.

Kazuaki Takahashi, Masataka Takenaka, Ayako Kawabata

Pageof 1

Frequent Collaborators

3 joint publications

Motoaki Saito

3 joint publications

Kyosuke Yamada

3 joint publications

Hirokuni Takano

3 joint publications

Aikou Okamoto